What is Protagonist Therapeutics, Inc's Market Cap?

Protagonist Therapeutics, Inc's Market Cap is $9.4B, based on as-reported figures from SEC (XBRL) filings.

What is Protagonist Therapeutics, Inc's Enterprise Value?

Protagonist Therapeutics, Inc's Enterprise Value is $8.7B, based on as-reported figures from SEC (XBRL) filings.

What is Protagonist Therapeutics, Inc's Trailing P/E?

Protagonist Therapeutics, Inc's Trailing P/E is 113.9×, based on as-reported figures from SEC (XBRL) filings.

What is Protagonist Therapeutics, Inc's Price / Sales?

Protagonist Therapeutics, Inc's Price / Sales is 205.2×, based on as-reported figures from SEC (XBRL) filings.

What is Protagonist Therapeutics, Inc's EV / Revenue?

Protagonist Therapeutics, Inc's EV / Revenue is 188.2×, based on as-reported figures from SEC (XBRL) filings.

What is Protagonist Therapeutics, Inc's EV / EBITDA?

Protagonist Therapeutics, Inc's EV / EBITDA is 144.4×, based on as-reported figures from SEC (XBRL) filings.

What is Protagonist Therapeutics, Inc's Revenue (TTM)?

Protagonist Therapeutics, Inc's Revenue (TTM) is $46.0M, based on as-reported figures from SEC (XBRL) filings.

What is Protagonist Therapeutics, Inc's Net Income (TTM)?

Protagonist Therapeutics, Inc's Net Income (TTM) is $82.9M, based on as-reported figures from SEC (XBRL) filings.

What is Protagonist Therapeutics, Inc's EBITDA?

Protagonist Therapeutics, Inc's EBITDA is $59.9M, based on as-reported figures from SEC (XBRL) filings.

What is Protagonist Therapeutics, Inc's Diluted EPS (TTM)?

Protagonist Therapeutics, Inc's Diluted EPS (TTM) is 1.28, based on as-reported figures from SEC (XBRL) filings.

Protagonist Therapeutics, Inc (PTGX) Financial Statements

Protagonist Therapeutics, Inc

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG002B63KP4

XNAS · usd

145.94▲ 0.22 (0.15%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close145.72

Day's Range142.00 – 147.29

52-Week Range54.50 – 160.81

Volume635.0K

Avg Volume487.8K

Share Statistics

Shares Outstanding

Employees132

ExchangeXNAS

Listed2016-08-11

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Protagonist Therapeutics, Inc (PTGX)

What is Protagonist Therapeutics, Inc's Market Cap?: Protagonist Therapeutics, Inc's Market Cap is $9.4B, based on as-reported figures from SEC (XBRL) filings.
What is Protagonist Therapeutics, Inc's Enterprise Value?: Protagonist Therapeutics, Inc's Enterprise Value is $8.7B, based on as-reported figures from SEC (XBRL) filings.
What is Protagonist Therapeutics, Inc's Trailing P/E?: Protagonist Therapeutics, Inc's Trailing P/E is 113.9×, based on as-reported figures from SEC (XBRL) filings.
What is Protagonist Therapeutics, Inc's Price / Sales?: Protagonist Therapeutics, Inc's Price / Sales is 205.2×, based on as-reported figures from SEC (XBRL) filings.
What is Protagonist Therapeutics, Inc's EV / Revenue?: Protagonist Therapeutics, Inc's EV / Revenue is 188.2×, based on as-reported figures from SEC (XBRL) filings.
What is Protagonist Therapeutics, Inc's EV / EBITDA?: Protagonist Therapeutics, Inc's EV / EBITDA is 144.4×, based on as-reported figures from SEC (XBRL) filings.
What is Protagonist Therapeutics, Inc's Revenue (TTM)?: Protagonist Therapeutics, Inc's Revenue (TTM) is $46.0M, based on as-reported figures from SEC (XBRL) filings.
What is Protagonist Therapeutics, Inc's Net Income (TTM)?: Protagonist Therapeutics, Inc's Net Income (TTM) is $82.9M, based on as-reported figures from SEC (XBRL) filings.
What is Protagonist Therapeutics, Inc's EBITDA?: Protagonist Therapeutics, Inc's EBITDA is $59.9M, based on as-reported figures from SEC (XBRL) filings.
What is Protagonist Therapeutics, Inc's Diluted EPS (TTM)?: Protagonist Therapeutics, Inc's Diluted EPS (TTM) is 1.28, based on as-reported figures from SEC (XBRL) filings.